Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic

Med Pediatr Oncol. 2000 Nov;35(5):493-5. doi: 10.1002/1096-911x(20001101)35:5<493::aid-mpo9>3.0.co;2-p.
No abstract available

MeSH terms

  • Analysis of Variance
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Chromosomes, Human, Pair 11 / genetics
  • Czech Republic / epidemiology
  • DNA-Binding Proteins / genetics
  • Daunorubicin / administration & dosage
  • Diploidy
  • Disease-Free Survival
  • Female
  • Genetic Predisposition to Disease
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Myeloid-Lymphoid Leukemia Protein
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Prednisone / administration & dosage
  • Prognosis
  • Proto-Oncogenes*
  • Risk Factors
  • Transcription Factors*
  • Translocation, Genetic
  • Vincristine / administration & dosage

Substances

  • DNA-Binding Proteins
  • KMT2A protein, human
  • Transcription Factors
  • Myeloid-Lymphoid Leukemia Protein
  • Vincristine
  • Histone-Lysine N-Methyltransferase
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol